This is a Validated Antibody Database (VAD) review about human SUMO-1, based on 131 published articles (read how Labome selects the articles), using SUMO-1 antibody in all methods. It is aimed to help Labome visitors find the most suited SUMO-1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SUMO-1 synonym: DAP1; GMP1; OFC10; PIC1; SENP2; SMT3; SMT3C; SMT3H3; UBL1

Invitrogen
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Invitrogen SUMO-1 antibody (ThermoFisher, PA5-11375) was used in western blot on human samples at 1:1000 (fig 5c). BMC Biol (2020) ncbi
mouse monoclonal (21C7)
  • western blot; human; loading ...; fig 1
In order to discover SUMO-paralog-specific conjugation of HDAC1, Invitrogen SUMO-1 antibody (Thermofisher, 33-2400) was used in western blot on human samples (fig 1). Methods Mol Biol (2017) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; Northern mole vole; 1:250; fig 3
  • immunocytochemistry; Zaisan mole vole; 1:250; fig 3
In order to characterize male XX chromosomes that recombine and undergo pachytene chromatin inactivation as a form of unique sex chromosome systems in Ellobius, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunocytochemistry on Northern mole vole samples at 1:250 (fig 3) and in immunocytochemistry on Zaisan mole vole samples at 1:250 (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1a
In order to assess inhibition of the SUMOylation of VCP that leads to impaired stress response by pathogenic mutations in the valosin-containing protein/p97(VCP) N-domain, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:500; fig 6
In order to characterize the rescue of hypersensitivity of Rnf4 mutant cells to DNA damage via loss of ubiquitin E2 Ube2w, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in western blot on human samples at 1:500 (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to analyze enhancement of binding with CDK2 and phosphorylation at early G1 phase by SUMOylationn of Rb, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples (fig 1). Cell Cycle (2016) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; tbl 1
In order to examine eosinophilic neuronal cytoplasmic inclusions, Invitrogen SUMO-1 antibody (Invitrogen, 21C7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 1). Neuropathology (2016) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:1000; fig 4a
In order to determine how reuglations of m TORC1 signalling occurs by SUMOylation of AMPK alpha 1 through PIAS4, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples at 1:1000 (fig 4a). Nat Commun (2015) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:1000; fig 1c
In order to describe a SUMO-specific protease-based methodology suitable for mass spectroscopy, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in western blot on human samples at 1:1000 (fig 1c). Nat Commun (2015) ncbi
mouse monoclonal (21C7)
  • ELISA; human
In order to use the HuProt array to screen the human proteome to identify novel SUMO E3 ligase substrates, Invitrogen SUMO-1 antibody (Life Technologies, 33-2400) was used in ELISA on human samples . Methods Mol Biol (2015) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; mouse; 1:100; fig s6
In order to study the promotion of recombination-dependent pachytene arrest in mouse spermatocytes due to the ATM signaling cascade, Invitrogen SUMO-1 antibody (Invitrogen, 21C7) was used in immunocytochemistry on mouse samples at 1:100 (fig s6). PLoS Genet (2015) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 9
In order to test if autophagic vacuoles formation is required for Abeta production by SUMO1, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 9). Autophagy (2015) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; rhesus macaque; fig 3
In order to determine if SUMOylation regulates the transcriptional activity of FOXA1, Invitrogen SUMO-1 antibody (Life Technologies, 33-2400) was used in immunoprecipitation on rhesus macaque samples (fig 3). Mol Endocrinol (2014) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:1000
In order to evaluate two two-component vector recombinant SUMOylation systems for the production of SUMO-modified protein, Invitrogen SUMO-1 antibody (Life Technologies, 33-2400) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 3, 4, 5
In order to analyze SUMOylation in neuroblastoma cells as it impairs deubiquitinating activity of CYLD, Invitrogen SUMO-1 antibody (Invitrogen, 21C7) was used in western blot on human samples (fig 3, 4, 5). Oncogene (2015) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry - paraffin section; human; 1:500
In order to investigate the association of eosinophilic neuronal cytoplasmic inclusions with stress granules and autophagy in two clinical cases, Invitrogen SUMO-1 antibody (Invitrogen, 21C7) was used in immunohistochemistry - paraffin section on human samples at 1:500. Neuropathology (2014) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:500
In order to report PINK1 phosphorylates ubiquitin which results in parkin activation, Invitrogen SUMO-1 antibody (ZYMED, 21C7) was used in western blot on human samples at 1:500. Nature (2014) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; human; 1:1000; fig 2
  • western blot; human; 1:1000; fig 1
In order to investigate the role of SUMOylation on FOXM1 activity, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunoprecipitation on human samples at 1:1000 (fig 2) and in western blot on human samples at 1:1000 (fig 1). Oncogene (2014) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to study the effect of SUMOylation on chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples . Nucleic Acids Res (2014) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to determine the post-translational modifications that regulate KDM5B, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples (fig 1). Epigenetics (2013) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry; mouse; 1:200; fig 1
In order to analyze how the DNA damage response is regulated on male meiotic sex chromosomes, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in immunohistochemistry on mouse samples at 1:200 (fig 1). Nat Commun (2013) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to identify 15d-PGJ(2) as an inhibitor of androgen signaling, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples (fig 1). Mol Endocrinol (2013) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry - paraffin section; human; 1:800
In order to investigate the association of giant cell polymyositis and myocarditis with myasthenia gravis and thymoma, Invitrogen SUMO-1 antibody (Zymed Laboratories, 21C7) was used in immunohistochemistry - paraffin section on human samples at 1:800. Neuropathology (2013) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry - paraffin section; human; 1:800; fig 1
In order to measure the extent and frequency of URP-immunoreactive inclusions in intranuclear inclusion body disease, Invitrogen SUMO-1 antibody (Invitrogen, clone 21C7) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 1). Pathol Int (2012) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to identify proteins that bind noncovalently to SUMO2, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on human samples (fig 1). J Virol (2012) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; rat; 1:100; fig 10
In order to report the temporal and spatial appearance of transcriptional and MSCI markers, as well as transcriptional regulated chromatin modifications, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunocytochemistry on rat samples at 1:100 (fig 10). Chromosoma (2012) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; human; fig 4
In order to describe methods to detect pp71-induced sumoylation of Daxx, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunoprecipitation on human samples (fig 4). Methods (2011) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; fig 6
In order to report that the effects of progerin are partially transduced by reduced function of Ran GTPase and SUMOylation pathways, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on human samples (fig 6). Mol Cell Biol (2011) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to investigate the contribution of small ubiquitin-related modifiers to Caenorhabditis elegans development, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in western blot on human samples (fig 1). Cell Mol Life Sci (2011) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry; rat; fig 7
  • western blot; human; fig 6
In order to report that sumoylation regulates the nuclear localization of DREAM in differentiated neurons, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunohistochemistry on rat samples (fig 7) and in western blot on human samples (fig 6). Biochim Biophys Acta (2011) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human
In order to identify a nucleolus-associated RNA-protein aggregate formed by proteasome activity inhibition in mammalian cells, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunocytochemistry on human samples . Oncogene (2011) ncbi
mouse monoclonal (21C7)
  • western blot; mouse; fig 4
In order to examine the cross-talk between glucocorticoid-induced leucine zipper and caspase-8 in dexamethasone-treated thymocytes, Invitrogen SUMO-1 antibody (Invitrogen, clone 21C7) was used in western blot on mouse samples (fig 4). Cell Death Differ (2011) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry - paraffin section; human; 1:800; fig 1
In order to report and characterize an incipient case of intranuclear inclusion body disease, Invitrogen SUMO-1 antibody (Invitrogen Corp., 21C7) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 1). Neuropathology (2011) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 5
In order to generate a protein microarray-based assay to measure post-translational modifications, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in western blot on human samples (fig 5). PLoS ONE (2010) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 6
In order to investigate how KLF4 and SUMO co-regulate gene expression, Invitrogen SUMO-1 antibody (Zymed Laboratories, 33-2400) was used in western blot on human samples (fig 6). J Biol Chem (2010) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry; mouse; 1:50; fig 1
  • western blot; mouse; 1:500; fig 4
In order to study the functions of sumoylation during mammalian meiosis, Invitrogen SUMO-1 antibody (ZYMED, clone 21C7) was used in immunohistochemistry on mouse samples at 1:50 (fig 1) and in western blot on mouse samples at 1:500 (fig 4). Cell Cycle (2010) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; mouse; fig 2
In order to study the localization and function of Ret Finger Protein, Invitrogen SUMO-1 antibody (Zymed laboratories, 33-2400) was used in immunocytochemistry on mouse samples (fig 2). Int J Cell Biol (2009) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; chicken; 1:200
In order to examine when in the cell cycle Ig gene conversion occurs, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on chicken samples at 1:200. J Immunol (2009) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; rat; 1:50; fig s3
In order to identify how Robertsonian translocations occur and spread naturally, Invitrogen SUMO-1 antibody (ZYMED, 33?C2400) was used in immunocytochemistry on rat samples at 1:50 (fig s3). PLoS Genet (2009) ncbi
mouse monoclonal (21C7)
  • western blot; mouse; fig 1
In order to study post-translational modifications of PGC-1alpha, Invitrogen SUMO-1 antibody (Invitrogen, 33-2400) was used in western blot on mouse samples (fig 1). J Biol Chem (2009) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; human; fig 1
  • western blot; human; fig 1
In order to investigate if the nucleolus is the key organelle in which SUMO-1 conjugates accumulate in response to proteasome inhibition, Invitrogen SUMO-1 antibody (Zymed Laboratories, 21C7) was used in immunoprecipitation on human samples (fig 1) and in western blot on human samples (fig 1). Mol Cell Proteomics (2009) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to measure small ubiquitin-like modifier 1 expression in aseptic loosening of prosthesis implants and investigate its role in prosthesis-loosening fibroblast-like synoviocytes, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . Arthritis Rheum (2009) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 4
In order to identify interaction partners of M2-PK in order to discover novel links between M2-PK and cellular functions, Invitrogen SUMO-1 antibody (Zymed, 33-2,400) was used in western blot on human samples (fig 4). J Cell Biochem (2009) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; rat; 1:10; fig 2
In order to examine SUMOYLation enzymes in Cajal bodies, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on rat samples at 1:10 (fig 2). J Struct Biol (2008) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to investigate the cross-talk between sumoylation and ubiquitination, Invitrogen SUMO-1 antibody (Zymed Laboratories, 21C7) was used in western blot on human samples . Mol Cell Proteomics (2008) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to report that E1B-55K stimulates the post-translational modification of p53 by SUMOYlation, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . Cell Cycle (2008) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to identify and characterize the primary sumoylation site of Ets transcriptional repressor Tel (ETV6), Invitrogen SUMO-1 antibody (Zymed Laboratories, 21C7) was used in western blot on human samples (fig 1). Mol Cell Biol (2008) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; 1:50
  • western blot; human
In order to assess whether SUMO-1, SUMO-2, and SUMO-3 form mixed chains in cells, Invitrogen SUMO-1 antibody (Zymed Laboratories, 21C7) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples . Mol Cell Proteomics (2008) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human
In order to identify the proteins concentrated in SUMO-1 nuclear bodies of UR61 cells, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on human samples . Chromosoma (2007) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry; mouse; 1:200
In order to assess the role of DMRT7 in gametogenesis, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunohistochemistry on mouse samples at 1:200. PLoS Genet (2007) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:200; fig 1
In order to show that the gamma 1 isoform of PLC associates with nuclear promyelocytic leukemia, Invitrogen SUMO-1 antibody (Invitrogen, 21C7) was used in western blot on human samples at 1:200 (fig 1). J Proteome Res (2007) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; fig 5
In order to develop an array-based multiplexed analysis of signaling pathways, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunocytochemistry on human samples (fig 5). Mol Cell Proteomics (2007) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; African green monkey; fig 5
  • western blot; African green monkey; fig 2
In order to study posttranslational modifications that modulate the P53-HIC1-SIRT1 regulatory loop, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunocytochemistry on African green monkey samples (fig 5) and in western blot on African green monkey samples (fig 2). Mol Cell Biol (2007) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to study sumoylation of thymine DNA glycosylase, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . Mol Cell Biol (2007) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; fig 5D
  • western blot; human; fig 5B
In order to show that Pc2 is the SUMO E3 ligase for homeodomain interacting protein kinase 2, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on human samples (fig 5D) and in western blot on human samples (fig 5B). Mol Cell (2006) ncbi
mouse monoclonal (21C7)
  • western blot; rat; fig 4
In order to investigate phenobarbital and pregnenolone-induced expression of murine double minute 2, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on rat samples (fig 4). Toxicol Sci (2006) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to investigate the target protein preferences of SUMO-1 and SUMO-2, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples (fig 1). Mol Cell Proteomics (2006) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; fig S7
In order to elucidate the role of promyelocytic leukemia nuclear bodies, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on human samples (fig S7). J Cell Sci (2006) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 1
In order to report that SUMOylation controls phosducin stability and function, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples (fig 1). J Biol Chem (2006) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; African green monkey
In order to report that nuclear aggregation and transcriptional alterations are not unique to polyQ-containing proteins, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on African green monkey samples . Neurobiol Dis (2005) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to study SUMO-1-modified immediate-early 1 and 2 proteins of human cytomegalovirus, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . Arch Virol (2005) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 3A
In order to elucidate how p14ARF alterations contribute to susceptibility to cutaneous melanoma, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples (fig 3A). Cell Cycle (2005) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; mouse
  • western blot; mouse
In order to report that repression by Net's NID involves sumoylation by Ubc9 and PIAS1, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunoprecipitation on mouse samples and in western blot on mouse samples . Oncogene (2005) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; rat; fig 2c
  • immunoprecipitation; human; fig 2b
In order to determine if sumoylation modulates the cellular localization of WT1, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunoprecipitation on rat samples (fig 2c) and in immunoprecipitation on human samples (fig 2b). Cancer Res (2004) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to investigate the role of sumoylation in the regulation of the transactivating function of PPARgamma2, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . Genes Cells (2004) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 3
In order to examine the functions of different Sp3 isoforms, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in western blot on human samples (fig 3). Cell Signal (2005) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to study the mechanism by which p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . J Biol Chem (2004) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 2
In order to propose that SUMO modification of IE1-72 kDa contributes to efficient human cytomegalovirus replication by promoting the accumulation of IE2-86 kDa, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples (fig 2). J Virol (2004) ncbi
mouse monoclonal (21C7)
  • EMSA; human; fig 8
In order to study the transcriptional regulation of Ad4 binding protein/steroidogenic factor 1, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in EMSA on human samples (fig 8). Mol Endocrinol (2004) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; human; fig 2
  • western blot; human; fig 2
In order to show that GATA-1 is sumoylated, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunoprecipitation on human samples (fig 2) and in western blot on human samples (fig 2). Proc Natl Acad Sci U S A (2004) ncbi
mouse monoclonal (21C7)
  • immunohistochemistry; human; 1:500; fig 2
  • western blot; human; fig 5
In order to propose that recruitment of SUMO-1 modified proteins into insoluble nuclear inclusions and proteasomal dysfunction may be involved in the pathogenesis of familiar neuronal intranuclear inclusion diseases, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunohistochemistry on human samples at 1:500 (fig 2) and in western blot on human samples (fig 5). Exp Neurol (2003) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; 1:400
  • immunocytochemistry; mouse
In order to determine the subcellular localization of BTBD1 and BTBD2, Invitrogen SUMO-1 antibody (Zymed, 33-2400) was used in immunocytochemistry on human samples at 1:400 and in immunocytochemistry on mouse samples . Exp Cell Res (2003) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; rat; fig 5a
  • western blot; human; fig 2
In order to study the sumoylation of adenovirus type 5 early region 1B 55-kDa oncoprotein, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunocytochemistry on rat samples (fig 5a) and in western blot on human samples (fig 2). Proc Natl Acad Sci U S A (2001) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; human; fig 4
In order to identify and study spectrin betaIV, Invitrogen SUMO-1 antibody (Zymed Laboratories, clone 21C7) was used in immunocytochemistry on human samples (fig 4). J Biol Chem (2001) ncbi
mouse monoclonal (21C7)
  • western blot; human; 1:1000
In order to examine the role of pescadilloin glial tumorigenesis, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples at 1:1000. J Biol Chem (2001) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to study sumolyation of the E1 protein, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . J Biol Chem (2000) ncbi
mouse monoclonal (21C7)
  • immunoprecipitation; human; 5 ug
  • western blot; human
In order to identify proteins that interact with bovine papillomavirus E1, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in immunoprecipitation on human samples at 5 ug and in western blot on human samples . J Biol Chem (2000) ncbi
mouse monoclonal (21C7)
  • immunocytochemistry; African green monkey; fig 5
  • western blot; African green monkey; fig 2
In order to report quantitative and qualitative differences between SUMO-1 and SUMO-2/3 in vertebrate cells, Invitrogen SUMO-1 antibody (Zymed Laboratories, clone 21C7) was used in immunocytochemistry on African green monkey samples (fig 5) and in western blot on African green monkey samples (fig 2). J Biol Chem (2000) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to identify binding partners of IE2 protein, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . J Virol (2000) ncbi
mouse monoclonal (21C7)
  • western blot; human
In order to study apoptosis induced by As2O3, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples . Mol Cell Biol (1999) ncbi
mouse monoclonal (21C7)
  • western blot; human; fig 2
In order to study SUMO-1-modified IkappaBalpha, Invitrogen SUMO-1 antibody (Zymed, 21C7) was used in western blot on human samples (fig 2). Mol Cell (1998) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-11)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 7s1a
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in immunohistochemistry on mouse samples at 1:200 (fig 7s1a). elife (2022) ncbi
mouse monoclonal (D-11)
  • western blot; mouse; loading ...; fig 1d
Santa Cruz Biotechnology SUMO-1 antibody (SANTA, sc-5308,) was used in western blot on mouse samples (fig 1d). Aging (Albany NY) (2021) ncbi
mouse monoclonal (D-11)
  • western blot; human; fig 6a
Santa Cruz Biotechnology SUMO-1 antibody (SantaCruz, sc-5308) was used in western blot on human samples (fig 6a). Cell Res (2018) ncbi
mouse monoclonal (D-11)
  • western blot; rat; loading ...; fig 6
In order to investigate the role of Ser25 phosphorylation in subcellular localization of Annexin A2 and its interaction with mRNP complexes, Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in western blot on rat samples (fig 6). FEBS Open Bio (2017) ncbi
mouse monoclonal (D-11)
  • immunoprecipitation; mouse; 1:200
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz biotechnology, sc-5308) was used in immunoprecipitation on mouse samples at 1:200. Nat Commun (2017) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:1000; fig st2
In order to study inhibition of growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex by ON 01910.Na, Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in western blot on human samples at 1:1000 (fig st2). Transl Res (2016) ncbi
mouse monoclonal (D-11)
  • chromatin immunoprecipitation; African green monkey; fig s5
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in chromatin immunoprecipitation on African green monkey samples (fig s5). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (D-11)
  • western blot; rat; 1:500; fig 1
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in western blot on rat samples at 1:500 (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (D-11)
  • western blot; human; fig 3b
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz Biotechnology, sc-5308) was used in western blot on human samples (fig 3b). Nucleic Acids Res (2015) ncbi
mouse monoclonal (D-11)
  • western blot; rat
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz Biotechnology, sc-5308) was used in western blot on rat samples . Cell Signal (2014) ncbi
mouse monoclonal (D-11)
  • western blot; human
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (D-11)
  • immunocytochemistry; human; 1:50
  • western blot; human
Santa Cruz Biotechnology SUMO-1 antibody (Santa Cruz, sc-5308) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples . J Biol Chem (2009) ncbi
Abcam
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:300; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; fig 4a
Abcam SUMO-1 antibody (Abcam, ab11672) was used in immunocytochemistry on human samples at 1:300 (fig 4b) and in western blot on human samples at 1:1000 (fig 4a). Int J Oncol (2020) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig 1a
Abcam SUMO-1 antibody (Abcam, EP298) was used in western blot on human samples (fig 1a). PLoS ONE (2019) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human; loading ...; fig 1a
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples (fig 1a). Cancer Lett (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
Abcam SUMO-1 antibody (Abcam, ab11672) was used in western blot on human samples (fig 6d). J Virol (2017) ncbi
domestic rabbit monoclonal (Y299)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2c
Abcam SUMO-1 antibody (Abcam, Y299) was used in immunohistochemistry - frozen section on mouse samples (fig 2c). PLoS Pathog (2016) ncbi
domestic rabbit monoclonal (Y299)
  • immunocytochemistry; human; 1:100; fig 3
  • western blot; human; 1:1000; fig st2
In order to study inhibition of growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex by ON 01910.Na, Abcam SUMO-1 antibody (Abcam, ab32058) was used in immunocytochemistry on human samples at 1:100 (fig 3) and in western blot on human samples at 1:1000 (fig st2). Transl Res (2016) ncbi
domestic rabbit monoclonal (Y299)
  • immunocytochemistry; mouse; 1:100; fig 1
Abcam SUMO-1 antibody (Abcam, ab32058) was used in immunocytochemistry on mouse samples at 1:100 (fig 1). Chromosoma (2016) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human; loading ...; fig 1a
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples (fig 1a). Nat Commun (2015) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human; 1:1000; fig 5c
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples at 1:1000 (fig 5c). Biomolecules (2015) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human; 1:1000
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human; 1:1000; fig 3e
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples at 1:1000 (fig 3e). Nat Neurosci (2014) ncbi
domestic rabbit monoclonal (Y299)
  • chromatin immunoprecipitation; human
Abcam SUMO-1 antibody (Abcam, ab32058) was used in chromatin immunoprecipitation on human samples . BMC Genomics (2013) ncbi
domestic rabbit monoclonal (Y299)
  • western blot; human
Abcam SUMO-1 antibody (Abcam, ab32058) was used in western blot on human samples . J Cell Biol (2013) ncbi
domestic rabbit monoclonal (Y299)
  • immunocytochemistry; human
Abcam SUMO-1 antibody (Abcam, ab32058) was used in immunocytochemistry on human samples . J Virol (2013) ncbi
domestic rabbit monoclonal (Y299)
  • immunocytochemistry; human; 1:250
  • western blot; human; 1:1000
Abcam SUMO-1 antibody (Abcam, ab32058) was used in immunocytochemistry on human samples at 1:250 and in western blot on human samples at 1:1000. Hum Reprod (2013) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology SUMO-1 antibody (Cell Signaling, 4930S) was used in western blot on human samples (fig 5b). Nat Commun (2020) ncbi
domestic rabbit monoclonal (C9H1)
  • western blot; mouse; 1:1000; loading ...; fig s9
Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, C9H1) was used in western blot on mouse samples at 1:1000 (fig s9). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, 4930) was used in western blot on human samples (fig 3). FASEB J (2019) ncbi
domestic rabbit monoclonal (C9H1)
  • immunoprecipitation; human; 1:1000; loading ...; fig s6b
  • western blot; human; 1:1000; loading ...; fig s6b
Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, C9H1) was used in immunoprecipitation on human samples at 1:1000 (fig s6b) and in western blot on human samples at 1:1000 (fig s6b). Nucleic Acids Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 4a
Cell Signaling Technology SUMO-1 antibody (Cell Signaling, 4930) was used in western blot on human samples at 1:2000 (fig 4a). Genes Dev (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 5a
In order to study the involvement of SENP1-mediated GATA2 deSUMOylation in graft arteriosclerosis, Cell Signaling Technology SUMO-1 antibody (Cell Signaling, 4930s) was used in western blot on mouse samples at 1:1000 (fig 5a). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4C
Cell Signaling Technology SUMO-1 antibody (Cell Signaling, 4930) was used in western blot on mouse samples at 1:1000 (fig 4C). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; fig 3c
Cell Signaling Technology SUMO-1 antibody (cell signalling, 4930) was used in immunocytochemistry on mouse samples (fig 3c). PLoS Pathog (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig s3
Cell Signaling Technology SUMO-1 antibody (Cell Signaling Tech, 4930) was used in western blot on human samples at 1:500 (fig s3). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
  • immunohistochemistry; mouse; loading ...; fig 6d
Cell Signaling Technology SUMO-1 antibody (cell signalling, 4930) was used in western blot on human samples (fig 3a) and in immunohistochemistry on mouse samples (fig 6d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; purple urchin; 1:100; fig 2a
In order to study Nanos localization and stability in the sea urchin, Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, 4930) was used in immunocytochemistry on purple urchin samples at 1:100 (fig 2a). Dev Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 8
In order to determine the necessity for differentiation-dependent viral life cycle by post-transciptional regulation of KLF4 by high-risk human papillomaviruses, Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, 4930S) was used in western blot on human samples (fig 8). PLoS Pathog (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1i
Cell Signaling Technology SUMO-1 antibody (Cell Signaling, 4930) was used in western blot on human samples (fig 1i). Nat Struct Mol Biol (2016) ncbi
domestic rabbit monoclonal (C9H1)
  • western blot; human; fig 6
In order to investigate the deficiency that affects SERCA expression and function in the skeletal muscle by Calpain 3, Cell Signaling Technology SUMO-1 antibody (Cell signaling, 4940S) was used in western blot on human samples (fig 6). Expert Rev Mol Med (2016) ncbi
domestic rabbit monoclonal (C9H1)
In order to characterize PXR biology and a SUMO-acetyl switch, Cell Signaling Technology SUMO-1 antibody (Cell Signaling, C9H1) was used . Biochim Biophys Acta (2016) ncbi
domestic rabbit monoclonal (C9H1)
  • western blot; mouse; fig 1
Cell Signaling Technology SUMO-1 antibody (Cell Signaling, C9H1) was used in western blot on mouse samples (fig 1). Drug Metab Dispos (2015) ncbi
domestic rabbit monoclonal (C9H1)
  • western blot; mouse
Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, 4940) was used in western blot on mouse samples . J Cell Mol Med (2015) ncbi
domestic rabbit monoclonal (C9H1)
  • immunohistochemistry - paraffin section; mouse
  • western blot; mouse; 1:200
In order to profile SUMOylation components during mouse brain development, Cell Signaling Technology SUMO-1 antibody (Cell Signaling Technology, 4940) was used in immunohistochemistry - paraffin section on mouse samples and in western blot on mouse samples at 1:200. J Comp Neurol (2014) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (SUMO-1 21C7)
  • immunohistochemistry; mouse; fig 1
  • western blot; mouse; fig 1
Developmental Studies Hybridoma Bank SUMO-1 antibody (DSHB, 21C7) was used in immunohistochemistry on mouse samples (fig 1) and in western blot on mouse samples (fig 1). Neuroscience (2017) ncbi
mouse monoclonal (SUMO-1 21C7)
  • western blot; rat; 1:1000; loading ...; fig 1b
Developmental Studies Hybridoma Bank SUMO-1 antibody (hybridoma bank, 21C7) was used in western blot on rat samples at 1:1000 (fig 1b). Nat Commun (2016) ncbi
mouse monoclonal (SUMO-1 21C7)
  • western blot; mouse; 1:1000; fig 1
Developmental Studies Hybridoma Bank SUMO-1 antibody (DSHB, 21C7) was used in western blot on mouse samples at 1:1000 (fig 1). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (SUMO-1 21C7)
  • immunocytochemistry; rat; 1:250; fig 1
Developmental Studies Hybridoma Bank SUMO-1 antibody (Developmental Studies Hybridoma Bank, 21C7) was used in immunocytochemistry on rat samples at 1:250 (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (SUMO-1 21C7)
  • western blot; human; fig 2
Developmental Studies Hybridoma Bank SUMO-1 antibody (DSHB, 21C7) was used in western blot on human samples (fig 2). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (SUMO-1 21C7)
  • western blot; rat
Developmental Studies Hybridoma Bank SUMO-1 antibody (University of Iowa Hybridoma Bank, 21C7) was used in western blot on rat samples . Cell Signal (2014) ncbi
mouse monoclonal (SUMO-1 21C7)
  • western blot; human
Developmental Studies Hybridoma Bank SUMO-1 antibody (Developmental Studies Hybridoma Bank, 21C7) was used in western blot on human samples . Biochem J (2013) ncbi
MBL International
mouse monoclonal (5B12)
  • western blot; human; loading ...; fig 3a
MBL International SUMO-1 antibody (MBL, 5B12) was used in western blot on human samples (fig 3a). Toxicol Appl Pharmacol (2018) ncbi
mouse monoclonal (5B12)
  • immunocytochemistry; mouse; fig 4c
MBL International SUMO-1 antibody (MBL, 5B12) was used in immunocytochemistry on mouse samples (fig 4c). PLoS Pathog (2016) ncbi
Articles Reviewed
  1. Yoshioka N, Kurose M, Yano M, Tran D, Okuda S, Mori Ochiai Y, et al. Isoform-specific mutation in Dystonin-b gene causes late-onset protein aggregate myopathy and cardiomyopathy. elife. 2022;11: pubmed publisher
  2. Wang H, Xiong W, Hang S, Wang Y, Zhang S, Liu S. Depletion of SENP1-mediated PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive decline by aggravating microglia-mediated neuroinflammation. Aging (Albany NY). 2021;13:15240-15254 pubmed publisher
  3. Jiang Z, Zhang C, Liu X, Ma X, Bian X, Xiao X, et al. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4. Int J Oncol. 2020;57:780-790 pubmed publisher
  4. Szymura S, Bernal G, Wu L, Zhang Z, Crawley C, Voce D, et al. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy. BMC Biol. 2020;18:32 pubmed publisher
  5. Zhou J, Cui S, He Q, Guo Y, Pan X, Zhang P, et al. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat Commun. 2020;11:240 pubmed publisher
  6. Bentz G, Lowrey A, Horne D, Nguyen V, Satterfield A, Ross T, et al. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency. PLoS ONE. 2019;14:e0217578 pubmed publisher
  7. He Z, Zhang J, Huang Z, Du Q, Li N, Zhang Q, et al. Sumoylation of RORγt regulates TH17 differentiation and thymocyte development. Nat Commun. 2018;9:4870 pubmed publisher
  8. Hirano S, Udagawa O, Kobayashi Y, Kato A. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells. Toxicol Appl Pharmacol. 2018;360:150-159 pubmed publisher
  9. Xiao N, Li H, Yu W, Gu C, Fang H, Peng Y, et al. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation. FASEB J. 2019;33:163-174 pubmed publisher
  10. LI Y, Du L, Aldana Masangkay G, Wang X, Urak R, Forman S, et al. Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Res. 2018;: pubmed publisher
  11. Yu F, Shi G, Cheng S, Chen J, Wu S, Wang Z, et al. SUMO suppresses and MYC amplifies transcription globally by regulating CDK9 sumoylation. Cell Res. 2018;28:670-685 pubmed publisher
  12. Liang Z, Yang Y, He Y, Yang P, Wang X, He G, et al. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett. 2017;411:90-99 pubmed publisher
  13. Yue X, Zhang C, Zhao Y, Liu J, Lin A, Tan V, et al. Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression. Genes Dev. 2017;31:1641-1654 pubmed publisher
  14. Chen S, Jeng K, Lai M. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs. J Virol. 2017;91: pubmed publisher
  15. Qiu C, Wang Y, Zhao H, Qin L, Shi Y, Zhu X, et al. The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis. Nat Commun. 2017;8:15426 pubmed publisher
  16. Aukrust I, Rosenberg L, Ankerud M, Bertelsen V, Hollås H, Saraste J, et al. Post-translational modifications of Annexin A2 are linked to its association with perinuclear nonpolysomal mRNP complexes. FEBS Open Bio. 2017;7:160-173 pubmed publisher
  17. Brügger V, Duman M, Bochud M, Münger E, Heller M, Ruff S, et al. Delaying histone deacetylase response to injury accelerates conversion into repair Schwann cells and nerve regeneration. Nat Commun. 2017;8:14272 pubmed publisher
  18. Chakraborty K, Raundhal M, Chen B, Morse C, Tyurina Y, Khare A, et al. The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia. Nat Commun. 2017;8:13944 pubmed publisher
  19. Zhang L, Liu X, Sheng H, Liu S, Li Y, Zhao J, et al. Neuron-specific SUMO knockdown suppresses global gene expression response and worsens functional outcome after transient forebrain ischemia in mice. Neuroscience. 2017;343:190-212 pubmed publisher
  20. Ghosh H, Auguadri L, Battaglia S, Simone Thirouin Z, Zemoura K, Messner S, et al. Several posttranslational modifications act in concert to regulate gephyrin scaffolding and GABAergic transmission. Nat Commun. 2016;7:13365 pubmed publisher
  21. Citro S, Chiocca S. Assessing the Role of Paralog-Specific Sumoylation of HDAC1. Methods Mol Biol. 2017;1510:329-337 pubmed
  22. Maroui M, Callé A, Cohen C, Streichenberger N, Texier P, Takissian J, et al. Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment. PLoS Pathog. 2016;12:e1005834 pubmed publisher
  23. Du L, LI Y, Fakih M, Wiatrek R, Duldulao M, Chen Z, et al. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat Commun. 2016;7:12326 pubmed publisher
  24. Wu J, Lei H, Zhang J, Chen X, Tang C, Wang W, et al. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation. Oncotarget. 2016;7:58995-59005 pubmed publisher
  25. Matveevsky S, Bakloushinskaya I, Kolomiets O. Unique sex chromosome systems in Ellobius: How do male XX chromosomes recombine and undergo pachytene chromatin inactivation?. Sci Rep. 2016;6:29949 pubmed publisher
  26. Oulhen N, Wessel G. Differential Nanos 2 protein stability results in selective germ cell accumulation in the sea urchin. Dev Biol. 2016;418:146-156 pubmed publisher
  27. Gunasekharan V, Li Y, Andrade J, Laimins L. Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle. PLoS Pathog. 2016;12:e1005747 pubmed publisher
  28. Mo Z, Zhang Q, Liu Z, Lauer J, Shi Y, Sun L, et al. Neddylation requires glycyl-tRNA synthetase to protect activated E2. Nat Struct Mol Biol. 2016;23:730-7 pubmed publisher
  29. Wang T, Xu W, Qin M, Yang Y, Bao P, Shen F, et al. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response. J Biol Chem. 2016;291:14373-84 pubmed publisher
  30. Maure J, Moser S, Jaffray E, F Alpi A, Hay R. Loss of ubiquitin E2 Ube2w rescues hypersensitivity of Rnf4 mutant cells to DNA damage. Sci Rep. 2016;6:26178 pubmed publisher
  31. Meng F, Qian J, Yue H, Li X, Xue K. SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase. Cell Cycle. 2016;15:1724-32 pubmed publisher
  32. Dai Y, Hung L, Chen R, Lai C, Chang K. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex. Transl Res. 2016;175:129-143.e13 pubmed publisher
  33. Toral Ojeda I, Aldanondo G, Lasa Elgarresta J, Lasa Fernández H, Fernandez Torron R, Lopez de Munain A, et al. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. Expert Rev Mol Med. 2016;18:e7 pubmed publisher
  34. Juárez Vicente F, Luna Pelaez N, Garcia Dominguez M. The Sumo protease Senp7 is required for proper neuronal differentiation. Biochim Biophys Acta. 2016;1863:1490-8 pubmed publisher
  35. Ito M, Nakamura K, Mori F, Miki Y, Tanji K, Wakabayashi K. Novel eosinophilic neuronal cytoplasmic inclusions in the external cuneate nucleus of humans. Neuropathology. 2016;36:441-447 pubmed publisher
  36. Cui W, Sun M, Zhang S, Shen X, Galeva N, Williams T, et al. A SUMO-acetyl switch in PXR biology. Biochim Biophys Acta. 2016;1859:1170-1182 pubmed publisher
  37. Cloutier J, Mahadevaiah S, Elinati E, Tóth A, Turner J. Mammalian meiotic silencing exhibits sexually dimorphic features. Chromosoma. 2016;125:215-26 pubmed publisher
  38. Hua G, Paulen L, Chambon P. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression. Proc Natl Acad Sci U S A. 2016;113:E626-34 pubmed publisher
  39. Craig T, Anderson D, Evans A, Girach F, Henley J. SUMOylation of Syntaxin1A regulates presynaptic endocytosis. Sci Rep. 2015;5:17669 pubmed publisher
  40. Yan Y, Ollila S, Wong I, Vallenius T, Palvimo J, Vaahtomeri K, et al. SUMOylation of AMPKα1 by PIAS4 specifically regulates mTORC1 signalling. Nat Commun. 2015;6:8979 pubmed publisher
  41. Chen C, Zhu C, Huang J, Zhao X, Deng R, Zhang H, et al. SUMOylation of TARBP2 regulates miRNA/siRNA efficiency. Nat Commun. 2015;6:8899 pubmed publisher
  42. Mendes A, Grou C, Azevedo J, Pinto M. Evaluation of the activity and substrate specificity of the human SENP family of SUMO proteases. Biochim Biophys Acta. 2016;1863:139-47 pubmed publisher
  43. Bish R, Cuevas Polo N, Cheng Z, Hambardzumyan D, Munschauer M, Landthaler M, et al. Comprehensive Protein Interactome Analysis of a Key RNA Helicase: Detection of Novel Stress Granule Proteins. Biomolecules. 2015;5:1441-66 pubmed publisher
  44. Hendriks I, D Souza R, Chang J, Mann M, Vertegaal A. System-wide identification of wild-type SUMO-2 conjugation sites. Nat Commun. 2015;6:7289 pubmed publisher
  45. Cui W, Sun M, Galeva N, Williams T, Azuma Y, Staudinger J. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes. Drug Metab Dispos. 2015;43:1316-25 pubmed publisher
  46. Sidik S, Salsman J, Dellaire G, Rohde J. Shigella infection interferes with SUMOylation and increases PML-NB number. PLoS ONE. 2015;10:e0122585 pubmed publisher
  47. Cox E, Uzoma I, Guzzo C, Jeong J, Matunis M, Blackshaw S, et al. Identification of SUMO E3 ligase-specific substrates using the HuProt human proteome microarray. Methods Mol Biol. 2015;1295:455-63 pubmed publisher
  48. Pacheco S, Marcet Ortega M, Lange J, Jasin M, Keeney S, Roig I. The ATM signaling cascade promotes recombination-dependent pachytene arrest in mouse spermatocytes. PLoS Genet. 2015;11:e1005017 pubmed publisher
  49. Wu Z, Wang C, Bai M, Li X, Mei Q, Li X, et al. An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks. Nucleic Acids Res. 2015;43:3167-79 pubmed publisher
  50. Gorbunov N, McDaniel D, Zhai M, Liao P, Garrison B, Kiang J. Autophagy and mitochondrial remodelling in mouse mesenchymal stromal cells challenged with Staphylococcus epidermidis. J Cell Mol Med. 2015;19:1133-50 pubmed publisher
  51. Kalkat M, Chan P, Wasylishen A, Srikumar T, Kim S, Ponzielli R, et al. Identification of c-MYC SUMOylation by mass spectrometry. PLoS ONE. 2014;9:e115337 pubmed publisher
  52. Cho S, Yun S, Jo C, Lee D, Choi K, Song J, et al. SUMO1 promotes Aβ production via the modulation of autophagy. Autophagy. 2015;11:100-12 pubmed publisher
  53. Blakeslee W, Wysoczynski C, Fritz K, Nyborg J, Churchill M, McKinsey T. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism. Cell Signal. 2014;26:2912-20 pubmed publisher
  54. Sutinen P, Rahkama V, Rytinki M, Palvimo J. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation. Mol Endocrinol. 2014;28:1719-28 pubmed publisher
  55. Weber A, Schuermann D, Schär P. Versatile recombinant SUMOylation system for the production of SUMO-modified protein. PLoS ONE. 2014;9:e102157 pubmed publisher
  56. Kobayashi T, Masoumi K, Massoumi R. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. Oncogene. 2015;34:2251-60 pubmed publisher
  57. Mori F, Watanabe Y, Miki Y, Tanji K, Odagiri S, Eto K, et al. Ubiquitin-negative, eosinophilic neuronal cytoplasmic inclusions associated with stress granules and autophagy: an immunohistochemical investigation of two cases. Neuropathology. 2014;34:140-7 pubmed
  58. Katyal S, Lee Y, Nitiss K, Downing S, Li Y, Shimada M, et al. Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes. Nat Neurosci. 2014;17:813-21 pubmed publisher
  59. Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 2014;510:162-6 pubmed publisher
  60. Hasegawa Y, Yoshida D, Nakamura Y, Sakakibara S. Spatiotemporal distribution of SUMOylation components during mouse brain development. J Comp Neurol. 2014;522:3020-36 pubmed publisher
  61. Myatt S, Kongsema M, Man C, Kelly D, Gomes A, Khongkow P, et al. SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene. 2014;33:4316-29 pubmed publisher
  62. Wang W, Chen Y, Wang S, Hu N, Cao Z, Wang W, et al. PIASx? ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase. J Biol Chem. 2014;289:3217-30 pubmed publisher
  63. Chang P, Cheng C, Campbell M, Yang Y, Hsu H, Chang T, et al. The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation. BMC Genomics. 2013;14:824 pubmed publisher
  64. Paakinaho V, Kaikkonen S, Makkonen H, Benes V, Palvimo J. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res. 2014;42:1575-92 pubmed publisher
  65. Berndt A, Wilkinson K, Heimann M, Bishop P, Henley J. In vivo characterization of the properties of SUMO1-specific monobodies. Biochem J. 2013;456:385-95 pubmed publisher
  66. Bueno M, Richard S. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase. Epigenetics. 2013;8:1162-75 pubmed publisher
  67. Lu L, Xiong Y, Kuang H, Korakavi G, Yu X. Regulation of the DNA damage response on male meiotic sex chromosomes. Nat Commun. 2013;4:2105 pubmed publisher
  68. Poulsen S, Hansen R, Wagner S, van Cuijk L, van Belle G, Streicher W, et al. RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response. J Cell Biol. 2013;201:797-807 pubmed publisher
  69. Glass M, Everett R. Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol. 2013;87:2174-85 pubmed publisher
  70. Kaikkonen S, Paakinaho V, Sutinen P, Levonen A, Palvimo J. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells. Mol Endocrinol. 2013;27:212-23 pubmed publisher
  71. Vigodner M, Shrivastava V, Gutstein L, Schneider J, Nieves E, Goldstein M, et al. Localization and identification of sumoylated proteins in human sperm: excessive sumoylation is a marker of defective spermatozoa. Hum Reprod. 2013;28:210-23 pubmed publisher
  72. Kon T, Mori F, Tanji K, Miki Y, Kimura T, Wakabayashi K. Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma. Neuropathology. 2013;33:281-7 pubmed publisher
  73. Mori F, Tanji K, Odagiri S, Hattori M, Hoshikawa Y, Kono C, et al. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Pathol Int. 2012;62:407-11 pubmed publisher
  74. Li R, Wang L, Liao G, Guzzo C, Matunis M, Zhu H, et al. SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J Virol. 2012;86:5412-21 pubmed publisher
  75. Page J, de la Fuente R, Manterola M, Parra M, Viera A, Berríos S, et al. Inactivation or non-reactivation: what accounts better for the silence of sex chromosomes during mammalian male meiosis?. Chromosoma. 2012;121:307-26 pubmed publisher
  76. Hwang J, Kalejta R. In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation. Methods. 2011;55:160-5 pubmed publisher
  77. Kelley J, Datta S, Snow C, Chatterjee M, Ni L, Spencer A, et al. The defective nuclear lamina in Hutchinson-gilford progeria syndrome disrupts the nucleocytoplasmic Ran gradient and inhibits nuclear localization of Ubc9. Mol Cell Biol. 2011;31:3378-95 pubmed publisher
  78. Rytinki M, Lakso M, Pehkonen P, Aarnio V, Reisner K, PERAKYLA M, et al. Overexpression of SUMO perturbs the growth and development of Caenorhabditis elegans. Cell Mol Life Sci. 2011;68:3219-32 pubmed publisher
  79. Palczewska M, Casafont I, Ghimire K, Rojas A, Valencia A, Lafarga M, et al. Sumoylation regulates nuclear localization of repressor DREAM. Biochim Biophys Acta. 2011;1813:1050-8 pubmed publisher
  80. Latonen L, Moore H, Bai B, Jäämaa S, Laiho M. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability. Oncogene. 2011;30:790-805 pubmed publisher
  81. Delfino D, Spinicelli S, Pozzesi N, Pierangeli S, Velardi E, Bruscoli S, et al. Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes. Cell Death Differ. 2011;18:183-90 pubmed publisher
  82. Mori F, Miki Y, Tanji K, Ogura E, Yagihashi N, Jensen P, et al. Incipient intranuclear inclusion body disease in a 78-year-old woman. Neuropathology. 2011;31:188-93 pubmed publisher
  83. Del Rincón S, Rogers J, Widschwendter M, Sun D, Sieburg H, Spruck C. Development and validation of a method for profiling post-translational modification activities using protein microarrays. PLoS ONE. 2010;5:e11332 pubmed publisher
  84. Du J, McConnell B, Yang V. A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Krüppel-like factor 4. J Biol Chem. 2010;285:28298-308 pubmed publisher
  85. Wang Z, Ou X, Tong J, Li S, Wei L, Ouyang Y, et al. The SUMO pathway functions in mouse oocyte maturation. Cell Cycle. 2010;9:2640-6 pubmed
  86. Gillot I, Matthews C, Puel D, Vidal F, Lopez P. Ret Finger Protein: An E3 Ubiquitin Ligase Juxtaposed to the XY Body in Meiosis. Int J Cell Biol. 2009;2009:524858 pubmed publisher
  87. Ordinario E, Yabuki M, Larson R, Maizels N. Temporal regulation of Ig gene diversification revealed by single-cell imaging. J Immunol. 2009;183:4545-53 pubmed publisher
  88. Manterola M, Page J, Vasco C, Berríos S, Parra M, Viera A, et al. A high incidence of meiotic silencing of unsynapsed chromatin is not associated with substantial pachytene loss in heterozygous male mice carrying multiple simple robertsonian translocations. PLoS Genet. 2009;5:e1000625 pubmed publisher
  89. Rytinki M, Palvimo J. SUMOylation attenuates the function of PGC-1alpha. J Biol Chem. 2009;284:26184-93 pubmed publisher
  90. Matafora V, D Amato A, Mori S, Blasi F, Bachi A. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol Cell Proteomics. 2009;8:2243-55 pubmed publisher
  91. Meinecke I, Pap G, Mendoza H, Drange S, Ender S, Strietholt S, et al. Small ubiquitin-like modifier 1 [corrected] mediates the resistance of prosthesis-loosening fibroblast-like synoviocytes against Fas-induced apoptosis. Arthritis Rheum. 2009;60:2065-70 pubmed publisher
  92. Spoden G, Morandell D, Ehehalt D, Fiedler M, Jansen Durr P, Hermann M, et al. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2. J Cell Biochem. 2009;107:293-302 pubmed publisher
  93. Nayak A, Glöckner Pagel J, Vaeth M, Schumann J, Buttmann M, Bopp T, et al. Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J Biol Chem. 2009;284:10935-46 pubmed publisher
  94. Navascues J, Bengoechea R, Tapia O, Casafont I, Berciano M, Lafarga M. SUMO-1 transiently localizes to Cajal bodies in mammalian neurons. J Struct Biol. 2008;163:137-46 pubmed publisher
  95. Schimmel J, Larsen K, Matic I, van Hagen M, Cox J, Mann M, et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics. 2008;7:2107-22 pubmed publisher
  96. Muller S, Dobner T. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53. Cell Cycle. 2008;7:754-8 pubmed
  97. Roukens M, Alloul Ramdhani M, Vertegaal A, Anvarian Z, Balog C, Deelder A, et al. Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function. Mol Cell Biol. 2008;28:2342-57 pubmed publisher
  98. Matic I, van Hagen M, Schimmel J, Macek B, Ogg S, Tatham M, et al. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics. 2008;7:132-44 pubmed publisher
  99. Navascues J, Bengoechea R, Tapia O, Vaque J, Lafarga M, Berciano M. Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells. Chromosoma. 2007;116:441-51 pubmed
  100. Kim S, Namekawa S, Niswander L, Ward J, Lee J, Bardwell V, et al. A mammal-specific Doublesex homolog associates with male sex chromatin and is required for male meiosis. PLoS Genet. 2007;3:e62 pubmed
  101. Ferguson B, Dovey C, Lilley K, Wyllie A, Rich T. Nuclear phospholipase C gamma: punctate distribution and association with the promyelocytic leukemia protein. J Proteome Res. 2007;6:2027-32 pubmed
  102. Zanardi A, Giorgetti L, Botrugno O, Minucci S, Milani P, Pelicci P, et al. Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells. Mol Cell Proteomics. 2007;6:939-47 pubmed
  103. Stankovic Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Guerardel C, et al. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol. 2007;27:2661-75 pubmed
  104. Mohan R, Rao A, Gagliardi J, Tini M. SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment. Mol Cell Biol. 2007;27:229-43 pubmed
  105. Roscic A, Möller A, Calzado M, Renner F, Wimmer V, Gresko E, et al. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell. 2006;24:77-89 pubmed
  106. Nelson D, Bhaskaran V, Foster W, Lehman McKeeman L. p53-independent induction of rat hepatic Mdm2 following administration of phenobarbital and pregnenolone 16alpha-carbonitrile. Toxicol Sci. 2006;94:272-80 pubmed
  107. Vertegaal A, Andersen J, Ogg S, Hay R, Mann M, Lamond A. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics. 2006;5:2298-310 pubmed
  108. Dellaire G, Ching R, Dehghani H, Ren Y, Bazett Jones D. The number of PML nuclear bodies increases in early S phase by a fission mechanism. J Cell Sci. 2006;119:1026-33 pubmed
  109. Klenk C, Humrich J, Quitterer U, Lohse M. SUMO-1 controls the protein stability and the biological function of phosducin. J Biol Chem. 2006;281:8357-64 pubmed
  110. Fu L, Gao Y, Sztul E. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Neurobiol Dis. 2005;20:656-65 pubmed
  111. Sadanari H, Yamada R, Ohnishi K, Matsubara K, Tanaka J. SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein. Arch Virol. 2005;150:1763-82 pubmed
  112. Rizos H, Woodruff S, Kefford R. p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners. Cell Cycle. 2005;4:597-603 pubmed
  113. Wasylyk C, Criqui Filipe P, Wasylyk B. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net. Oncogene. 2005;24:820-8 pubmed
  114. Smolen G, Vassileva M, Wells J, Matunis M, Haber D. SUMO-1 modification of the Wilms' tumor suppressor WT1. Cancer Res. 2004;64:7846-51 pubmed
  115. Yamashita D, Yamaguchi T, Shimizu M, Nakata N, Hirose F, Osumi T. The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain. Genes Cells. 2004;9:1017-29 pubmed
  116. Spengler M, Kennett S, Moorefield K, Simmons S, Brattain M, Horowitz J. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. Cell Signal. 2005;17:153-66 pubmed
  117. Woods Y, Xirodimas D, Prescott A, Sparks A, Lane D, Saville M. p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase. J Biol Chem. 2004;279:50157-66 pubmed
  118. Nevels M, Brune W, Shenk T. SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol. 2004;78:7803-12 pubmed
  119. Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, Shirakawa M, et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol Endocrinol. 2004;18:2451-62 pubmed
  120. Collavin L, Gostissa M, Avolio F, Secco P, Ronchi A, Santoro C, et al. Modification of the erythroid transcription factor GATA-1 by SUMO-1. Proc Natl Acad Sci U S A. 2004;101:8870-5 pubmed
  121. Pountney D, Huang Y, Burns R, Haan E, Thompson P, Blumbergs P, et al. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol. 2003;184:436-46 pubmed
  122. Xu L, Yang L, Moitra P, Hashimoto K, Rallabhandi P, Kaul S, et al. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp Cell Res. 2003;288:84-93 pubmed
  123. Endter C, Kzhyshkowska J, Stauber R, Dobner T. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci U S A. 2001;98:11312-7 pubmed
  124. Tse W, Tang J, Jin O, Korsgren C, John K, Kung A, et al. A new spectrin, beta IV, has a major truncated isoform that associates with promyelocytic leukemia protein nuclear bodies and the nuclear matrix. J Biol Chem. 2001;276:23974-85 pubmed
  125. Kinoshita Y, Jarell A, Flaman J, Foltz G, Schuster J, Sopher B, et al. Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells. J Biol Chem. 2001;276:6656-65 pubmed
  126. Rangasamy D, Woytek K, Khan S, Wilson V. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J Biol Chem. 2000;275:37999-8004 pubmed
  127. Rangasamy D, Wilson V. Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein. J Biol Chem. 2000;275:30487-95 pubmed
  128. Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem. 2000;275:6252-8 pubmed
  129. Hofmann H, Flöss S, Stamminger T. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol. 2000;74:2510-24 pubmed
  130. Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann O, et al. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol. 1999;19:5170-8 pubmed
  131. Desterro J, Rodriguez M, Hay R. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell. 1998;2:233-9 pubmed